ArticleCureus2025
Frugal Innovation: A Modified Conduit to Enhance the Utility of Semirigid Thoracoscopy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The landscape of modern healthcare is becoming increasingly complex, with rising costs of diagnostic and therapeutic interventions. In low- and middle-income countries, such as India, affordability remains a major barrier to accessing advanced medical care. The All India Institute of Medical Sciences (AIIMS), Patna, India, was established with the aim of providing high-quality care at minimal cost, ensuring access even for the most underserved patients. Medical thoracoscopy is an invaluable diagnostic and therapeutic procedure for pleural diseases. Semirigid thoracoscopes, such as the Olympus EVIS EXERA LTF-160 (Olympus America, Center Valley, PA, USA), allow direct visualization and biopsy of pleural pathology under local anesthesia. However, their use is restricted in resource-limited settings due to the high cost of proprietary accessories, specifically the single-use trocar and cannula systems (e.g., Olympus MAJ-1058, Olympus Medical Systems Corp., Tokyo, Japan), which are not economically viable for repeated use in underfunded public healthcare systems. To address this challenge, we developed a frugal and functional innovation to replace the proprietary trocar-cannula system. This system integrates a reusable surgical accessory with a nonreusable medical device to substitute for the costly, manufacturer-provided single-use accessory. This report presents the technique, cost-benefit analysis, and preliminary safety evaluation of this innovation in clinical use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.